Adaptive Biotechnologies Corp. · 1 month ago
Clinical Lab Technologist
Adaptive Biotechnologies Corp. is focused on harnessing the power of the adaptive immune system to transform disease diagnosis and treatment. The Clinical Lab Technologist will process biological samples and perform next-generation DNA sequencing assays, ensuring compliance with regulatory requirements while working in a fast-paced laboratory environment.
BiotechnologyHealth CareTherapeutics
Responsibilities
Performs and provides general support for DNA extractions, PCR amplification, or high-throughput sequencing assays on DNA libraries in accordance with standard laboratory processes and procedures
Operates and maintains laboratory equipment such as liquid handling robotics and DNA sequencers
Completes tasks as assigned (e.g. routine clinical or research sample processing, validations, reagent QC runs, or special projects) accurately while following strict methodologies
Provides guidance to less-experienced staff
Performs training and/or competency assessments for Clinical Laboratory Technician/Technologist team members on high complexity molecular methods
Suggests changes to existing laboratory procedures and processes to improve efficiency and results
Maintains continuing education credit requirements
Records nonconformances for all appropriate errors
Enters and tracks data in a laboratory information database (LIMS)
Operates and maintains laboratory equipment such as liquid handling robotics and DNA sequencers
Qualification
Required
Molecular biology skills (e.g. DNA Extraction, Purification, PCR, qPCR, next-generation DNA sequencing) and related technical knowledge
Experience working with human specimens (e.g. blood, tissues and/or cells) and biohazardous material
Strong communication and interpersonal skills, ability to collaborate across teams and disciplines
Bachelor's or higher in medical technology or laboratory science from an accredited institution, OR:
Bachelor's or higher in one of the chemical or biological sciences from an accredited institution + 6 months of high-complexity molecular experience and/or training in a clinical laboratory (holding a CLIA Certificate of Compliance/Accreditation)
Bachelor's or higher in medical technology or laboratory science, chemical science, or biological science from an accredited institution
Minimum of 1 year of experience and/or training in a clinical laboratory (holding a CLIA Certificate of Compliance/Accreditation) meeting the definition of 'high-complexity'
Minimum of 3 years of pertinent molecular laboratory experience
Minimum of 2 years with a Master's or higher
Bachelor's or higher in medical technology or laboratory science, chemical science, or biological science from an accredited institution
Minimum of 3 years of experience and/or training in a clinical laboratory (holding a CLIA Certificate of Compliance/Accreditation) meeting the definition of 'high-complexity'
Minimum of 5 years of pertinent molecular laboratory experience
Competent in laboratory automation and demonstrated laboratory best practices
Preferred
ASCP(MB) certification
Specialized knowledge and skills: Experience in a clinical, high-throughput environment is preferred
Working knowledge of laboratory terminology, equipment, and supplies
Competent in laboratory automation and demonstrated laboratory best practices
Experience working within an electronic Laboratory Information Management System
Self-motivated and can work independently, with minimal supervision, while also working as part of a team environment in a dynamic organization
Strong interpersonal and communication skills, both written and spoken
Experience with Adaptive's Sample Prep or PCR/Sequencing technologies or Methods
Benefits
Equity grant
Bonus eligible
Company
Adaptive Biotechnologies Corp.
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.
Funding
Current Stage
Public CompanyTotal Funding
$531.85MKey Investors
OrbiMedARK Investment ManagementMatrix Capital Management
2022-09-12Post Ipo Debt· $125M
2022-03-24Post Ipo Equity
2020-07-14Post Ipo Equity
Recent News
2026-01-13
Company data provided by crunchbase